For US cosmetic brands—from small startups to established manufacturers—navigating FDA compliance for raw materials is non-negotiable. Unlike pharmaceuticals, the FDA does not “approve” cosmetic ingredients or finished products, but it enforces strict rules to ensure safety, transparency, and accountability. With the Modernization of Cosmetics Regulation Act (MoCRA) fully implemented in 2026, compliance requirements have become more rigorous, and non-compliance can lead to import detentions, product recalls, fines, or even a permanent ban from the US market. This guide breaks down the critical FDA compliance rules for cosmetic ingredients that every US brand must understand, with actionable steps to avoid common pitfalls and maintain regulatory adherence.
1. FDA’s Role in Cosmetic Ingredient Compliance
The US Food and Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and MoCRA—passed in 2022 and fully enforced by 2026. Unlike the European Union’s CPNP system, the FDA’s approach is “post-market surveillance,” meaning brands are responsible for ensuring their ingredients and products are safe before they reach consumers. The FDA’s primary focus for cosmetic ingredients is safety substantiation, restricted/prohibited substances, labeling accuracy, and traceability.
Key note: The FDA does not require pre-market approval for cosmetic ingredients (except for color additives). However, brands must be able to prove—with scientific evidence—that their ingredients are safe for their intended use. This burden of proof lies entirely with the brand, making it critical to partner with suppliers who provide accurate, verifiable documentation.
2. Prohibited and Restricted Cosmetic Ingredients (2026 Update)
The FDA maintains a list of prohibited ingredients (substances that cannot be used in cosmetics under any circumstances) and restricted ingredients (substances that can be used only under specific conditions, such as concentration limits or labeling requirements). US brands must thoroughly vet every raw material to ensure it does not contain prohibited substances and adheres to restrictions for restricted ingredients.
Prohibited Ingredients to Avoid
Common prohibited ingredients include: mercury compounds (except for trace amounts in certain eye products), chloroform, vinyl chloride, bithionol, and certain coal-tar hair dyes. In 2026, the FDA expanded this list to include several synthetic fragrances linked to skin irritation and endocrine disruption—check the FDA’s latest “Prohibited Cosmetic Ingredients” list (updated quarterly) to stay current.
Restricted Ingredients: Key Examples for 2026
- Hydroquinone: Once a common skin-brightening ingredient, hydroquinone is now restricted to 2% concentration in over-the-counter products; prescription-strength hydroquinone (4%) is not allowed in cosmetics.
- Sunscreen Actives: Only 16 sunscreen ingredients are FDA-approved for use in cosmetic products (e.g., zinc oxide, titanium dioxide, avobenzone). Any new sunscreen active requires FDA approval before use.
- Alpha Hydroxy Acids (AHAs): Restricted to concentrations ≤10% for leave-on products; must include a pH warning on labeling if pH <3.5.
Tip: Always request a Certificate of Analysis (CoA) from your raw material supplier to confirm ingredient purity and absence of prohibited substances. For restricted ingredients, ask for documentation proving compliance with concentration limits.
3. Safety Substantiation: The Foundation of FDA Compliance
Under the FD&C Act and MoCRA, US cosmetic brands must “substantiate the safety” of all ingredients used in their products. Safety substantiation means having scientific evidence—such as clinical studies, toxicological data, or published research—that proves the ingredient is safe when used as intended (e.g., concentration, application method, frequency of use).
What Counts as Valid Safety Substantiation?
- In-house or third-party clinical studies on the ingredient (preferred by the FDA).
- Toxicological assessments (e.g., acute oral toxicity, skin irritation testing) conducted by an accredited lab.
- Published peer-reviewed research on the ingredient’s safety.
- Compliance with the Cosmetic Ingredient Review (CIR) safety assessment—CIR is an independent body that evaluates cosmetic ingredient safety, and the FDA often defers to CIR conclusions.
Red Flag: Suppliers who cannot provide safety data or claim “all ingredients are safe” without evidence. For high-risk ingredients (e.g., active brighteners, anti-aging actives), invest in third-party safety testing to avoid liability.
4. MoCRA 2026: New Compliance Requirements for Ingredients
MoCRA (Modernization of Cosmetics Regulation Act) is the most significant update to US cosmetic regulation in 80 years, and its 2026 full enforcement brings new requirements specifically for raw materials:
Batch Traceability
Brands must maintain complete traceability records for every raw material batch, including: supplier name and contact information, batch number, receipt date, quantity received, and usage in finished products. This allows the FDA to trace any safety issues back to the source—critical for recalls or investigations.
Facility Registration
All facilities that manufacture, process, or package cosmetic ingredients for sale in the US must register with the FDA via the FDA’s Cosmetic Facility Registration Portal. This includes overseas suppliers—if your raw material supplier is based outside the US, they must be registered with the FDA to export to the US market.
Adverse Event Reporting
Brands must report serious adverse events (e.g., severe skin reactions, eye damage, hospitalization) related to their products to the FDA within 15 days. This includes adverse events caused by raw material contamination or improper use of ingredients.
5. Labeling Compliance for Cosmetic Ingredients
FDA labeling rules for cosmetic ingredients are strict, and non-compliant labeling is one of the most common reasons for FDA warnings. For US brands, ingredient labeling must meet the following requirements:
INCI Nomenclature
All ingredients must be listed using their International Nomenclature of Cosmetic Ingredients (INCI) names. For example, “alpha arbutin” must be listed as “Arbutin, α-” (not “skin brightener” or “natural extract”). This ensures transparency for consumers and regulators.
Ingredient Order
Ingredients must be listed in descending order of weight (from highest to lowest concentration). Ingredients that make up less than 1% of the product can be listed in any order after the 1% mark.
Required Warnings
Certain ingredients require specific warnings on the label. For example: AHAs require a “Keep out of eyes” warning; products containing SPF require a “Use as directed” warning; and restricted ingredients (e.g., hydroquinone) require a “For external use only” warning.
6. How to Ensure Your Raw Material Supplier is FDA Compliant
Your supplier’s compliance directly impacts your brand’s compliance. To avoid risks, vet every raw material supplier with these steps:
- Request FDA Facility Registration Proof: Ask for a copy of the supplier’s FDA registration certificate (for US facilities) or their FDA registration number (for overseas facilities).
- Verify Documentation: Demand batch-specific CoAs, Safety Data Sheets (SDS), and safety substantiation data for all ingredients. Ensure CoAs include purity, heavy metal limits, and microbial test results.
- Audit Quality Systems: Confirm the supplier follows Good Manufacturing Practices (GMP) for cosmetic ingredients—ask for a GMP audit report or virtual facility tour.
- Check for FDA Alerts: Search the FDA’s Import Alerts database to see if the supplier has a history of non-compliant shipments (e.g., prohibited ingredients, contaminated raw materials).
7. Common FDA Compliance Mistakes US Brands Make
Even experienced brands can fall into compliance traps. Avoid these common errors:
- Assuming “natural” or “organic” ingredients are automatically FDA-compliant—natural ingredients can still be prohibited or require safety substantiation.
- Using unapproved color additives—only FDA-listed color additives are allowed in cosmetics.
- Ignoring MoCRA traceability requirements—failing to track batch information can lead to FDA penalties.
- Relying solely on supplier claims—always verify safety data and compliance documents yourself.
FDA compliance for cosmetic ingredients is not a one-time task—it requires ongoing vigilance, especially with MoCRA’s 2026 enforcement. US brands must prioritize safety substantiation, traceability, and supplier vetting to avoid regulatory risks and protect their brand reputation. By understanding the FDA’s rules for prohibited/restricted ingredients, labeling, and MoCRA requirements, you can ensure your products meet US market standards and build trust with consumers and regulators alike.
For US brands seeking FDA-compliant cosmetic raw materials, partnering with a trusted supplier is critical. Dermareshine provides bulk cosmetic ingredients that meet FDA and MoCRA standards, with complete documentation (CoA, SDS, safety data), GMP-certified manufacturing, and FDA-registered facilities. Our team of regulatory experts can help you navigate compliance challenges, ensuring your raw materials are safe, legal, and ready for the US market.
Contact Dermareshine today to request a free sample and compliance consultation for your US cosmetic brand.